What alternative oral antihistamines can be used for itching in an adult who cannot take cetirizine (Zyrtec)?

Alternative Oral Antihistamines to Cetirizine for Itching in Adults

For adults who cannot take cetirizine, the best alternatives are desloratadine (5 mg once daily), fexofenadine (120-180 mg once daily), loratadine (10 mg once daily), or levocetirizine (5 mg once daily), as all are non-sedating H1-antihistamines with proven efficacy for pruritus. 1

First-Line Non-Sedating Alternatives

The British Journal of Dermatology guidelines identify seven non-sedating H1-antihistamines licensed for urticaria and pruritic conditions, all taken once daily except acrivastine 1:

Recommended Options (Once Daily Dosing)

• Desloratadine 5 mg: Has the longest elimination half-life at 27 hours, providing sustained coverage; effective for complete suppression of urticaria in intermediate-term treatment 1, 2

• Fexofenadine 120-180 mg: Produces small but measurable reductions in pruritus (mean reduction of 0.25 points on 0-8 scale) with no significant increase in adverse events compared to placebo 2

• Loratadine 10 mg: Well-established safety profile; shows anti-allergic effects on mast-cell mediator release at standard and higher doses 1, 3

• Levocetirizine 5 mg: The active enantiomer of cetirizine; effective at 5 mg in intermediate-term treatment, though may have similar sedation profile to cetirizine at higher doses 1, 2

• Mizolastine 10 mg: Once-daily option, but contraindicated in significant cardiac disease, QT prolongation, or concurrent use with CYP450 inhibitors (macrolides, azole antifungals) or drugs with arrhythmic potential 1

Important Comparative Data

Patients should be offered at least two different non-sedating H1-antihistamines as options, since individual responses and tolerance vary significantly (Strength of recommendation A) 1. When comparing agents directly:

• Levocetirizine appears more effective than desloratadine at equivalent doses (5-20 mg comparison, P < 0.02) 2
• Cetirizine shows greater complete suppression than fexofenadine (P < 0.001) 2
• Loratadine shows no significant difference compared to desloratadine, mizolastine, or emedastine for complete suppression or "good/excellent response" 2

Second-Line Sedating Alternatives

If non-sedating antihistamines fail or are contraindicated, sedating antihistamines can be effective but cause reduced concentration and performance 1:

• Hydroxyzine 10-50 mg: Demonstrated 750-fold increase in histamine dose required to produce pruritus (compared to 10-fold for diphenhydramine), making it the most effective antihistamine for pruritus suppression in comparative studies, though highly sedating 4

• Chlorphenamine (chlorpheniramine) 4-12 mg: Often chosen when antihistamine therapy is necessary due to long safety record, particularly in pregnancy 1

• Diphenhydramine: Produces 10-fold increase in histamine threshold for pruritus; commonly causes drowsiness 4

Special Considerations and Contraindications

Renal Impairment

• Avoid acrivastine in moderate renal impairment (CrCl 10-20 mL/min) 1
• Halve the dose of levocetirizine and hydroxyzine in moderate renal impairment 1
• Avoid levocetirizine in severe renal impairment (CrCl < 10 mL/min) 1
• Use loratadine and desloratadine with caution in severe renal impairment 1

Hepatic Impairment

• Mizolastine is contraindicated in significant hepatic impairment 1
• Avoid chlorphenamine and hydroxyzine in severe liver disease due to inappropriate sedating effects 1

Cardiac Considerations

• Mizolastine is contraindicated with clinically significant cardiac disease or QT prolongation 1
• Avoid concurrent use with drugs that prolong QT interval 1

Dosing Strategy

Standard dosing should be tried first, but increasing the dose above manufacturer's recommendations is common practice when benefits outweigh risks (Quality of evidence III, Strength of recommendation C) 1. Adjusting timing of medication to ensure highest drug levels when itching is anticipated can be helpful 1.

Common Pitfalls to Avoid

• Do not assume all non-sedating antihistamines are equally effective—individual variation is substantial 1
• Avoid using sedating antihistamines as monotherapy in patients requiring alertness for work or driving 1
• Do not combine mizolastine with macrolide antibiotics, azole antifungals, or tricyclic antidepressants 1
• Remember that acrivastine requires three-times-daily dosing, which may reduce compliance 1

Adjunctive Measures

Consider adding topical cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) for symptomatic relief 1. If a single H1-antihistamine fails, adding an H2-antihistamine may provide better control (Quality of evidence II, Strength of recommendation C), though this is more helpful for accompanying dyspepsia 1.